Mitropoulou Vivian, Trestman Robert L, New Antonia S, Flory Janine D, Silverman Jeremy M, Siever Larry J
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA.
CNS Spectr. 2003 Oct;8(10):725-30. doi: 10.1017/s109285290001909x.
Personality traits have been hypothesized to involve specific neurotransmitter systems. In order to test this model, the relationship between the responses to serotonergic and noradrenergic probes, central cerebrospinal fluid (CSF) measures of monoamine neurotransmitters and the Tridimensional Personality Questionnaire (TPQ) were evaluated in a cohort of personality disorder subjects.
A total of 142 patients meeting at least one personality disorder (meeting Diagnostic and Statistical Manual of Mental Disorders, Third Edition-Revised criteria) participated in these studies. The prolactin response to fenfluramine (a measure of serotonin function) was obtained for 110 subjects; growth hormone response to clonidine (a measure of noradrenergic function) was obtained for 77 subjects, while homovanillic acid (HVA) at baseline, an index of dopaminergic function, was available for 103 subjects. Measures of central neurotransmitter function (dopaminergic, serotonergic, and noradrenergic: HVA, 5-hydroxyindolacetic acid, and 3-methoxy-4-hydroxyphenylglycol, respectively) were available for 36 subjects. Separate regression analyses utilizing each of the hypothesized associations, where the TPQ total scores were used as the dependent measures and the biologic indices were the independent measures were conducted. Exploratory correlational analyses between these biologic measures and the four dimensions of the TPQ (and its subscales) were also conducted. (Correlations are reported if they would remain significant at P<.01 level after Bonferroni correction for multiple comparisons across the six neuroendocrine measures).
In the regression analyses, there was a trend association between CSF and plasma HVA in predicting novelty-seeking (P<.07). No other significant associations were found in the other three measures. Regarding the individual correlational analyses, the persistence scale of the TPQ was significantly positively correlated with the growth hormone response to clonidine (r=.30, P<.008). The sentimentality subscale (reward dependence) was positively correlated with CSF 5-hydroxyindolacetic acid (r=0.45, P<.001), while the attachment subscale (also reward dependence) was correlated with CSF 3-methoxy-4-hydroxyphenylglycol (r=0.49, P<.002).
Limited support was provided for a relationship between monoamines, particularly dopamine and novelty-seeking as well as norepinephrine and reward dependence but other hypothesized relationships were not supported by these measures.
有假说认为人格特质涉及特定的神经递质系统。为了验证该模型,在一组人格障碍受试者中评估了对血清素能和去甲肾上腺素能探针的反应、单胺神经递质的中枢脑脊液(CSF)测量值与三维人格问卷(TPQ)之间的关系。
共有142名至少符合一种人格障碍(符合《精神障碍诊断与统计手册》第三版修订标准)的患者参与了这些研究。110名受试者获得了对芬氟拉明的催乳素反应(血清素功能的一种测量方法);77名受试者获得了对可乐定的生长激素反应(去甲肾上腺素能功能的一种测量方法),而103名受试者可获得基线时的高香草酸(HVA),这是多巴胺能功能的一个指标。36名受试者可获得中枢神经递质功能的测量值(多巴胺能、血清素能和去甲肾上腺素能:分别为HVA、5-羟吲哚乙酸和3-甲氧基-4-羟基苯乙二醇)。利用每个假设的关联进行单独的回归分析,其中TPQ总分用作因变量,生物学指标用作自变量。还对这些生物学测量值与TPQ的四个维度(及其子量表)进行了探索性相关分析。(如果在对六种神经内分泌测量值进行多重比较的Bonferroni校正后,相关性在P<0.01水平仍显著,则报告相关性)。
在回归分析中,CSF和血浆HVA在预测寻求新奇性方面存在趋势性关联(P<0.07)。在其他三项测量中未发现其他显著关联。关于个体相关分析,TPQ的坚持性量表与对可乐定的生长激素反应显著正相关(r = 0.30,P<0.008)。多愁善感子量表(奖励依赖)与CSF 5-羟吲哚乙酸正相关(r = 0.45,P<0.001),而依恋子量表(也是奖励依赖)与CSF 3-甲氧基-4-羟基苯乙二醇相关(r = 0.49,P<0.002)。
单胺类物质之间的关系,特别是多巴胺与寻求新奇性以及去甲肾上腺素与奖励依赖之间的关系得到了有限的支持,但这些测量结果不支持其他假设的关系。